Kiora Pharmaceuticals, Inc.
KPRX • NASDAQ
Kiora Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Brian Strem, with a market cap of $6.9M.
CEOBrian Strem
Next Earnings
Upcoming earnings announcement for Kiora Pharmaceuticals, Inc.
Date
Friday, May 8, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.53
Revenue Estimate
$1.5M
Earnings History
Past 12 earnings reports for Kiora Pharmaceuticals, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Q4 2025 | -$1.60Est: -$0.54 | -196.3% | -Est: $1.5M | -100.0% |  10-K |
| Nov 7, 2025 | Q3 2025 | $0.01Est: -$0.72 | +101.4% | -Est: $750.0K | -100.0% | 10-Q |
| Aug 8, 2025 | Q2 2025 | -$0.54Est: -$0.58 | +6.9% | -Est: $750.0K | -100.0% | 10-Q |
| May 9, 2025 | Q1 2025 | -$0.52Est: -$0.77 | +32.5% | -Est: $750.0K | -100.0% | 10-Q |
| Mar 25, 2025 | Q4 2024 | -$0.99Est: -$0.70 | -41.4% | -Est: $750.0K | -100.0% | 10-K |
| Nov 8, 2024 | Q3 2024 | -$0.81Est: -$0.76 | -6.6% | -Est: $10.0K | -100.0% | 10-Q |
| Aug 9, 2024 | Q2 2024 | -$0.53Est: -$0.81 | +34.6% | $20.0K | — | 10-Q |
| May 10, 2024 | Q1 2024 | $3.42Est: -$0.90 | +480.0% | $16.0M | — | 10-Q |
| Mar 25, 2024 | Q4 2023 | $1.60 | — | - | — | 10-K |
| Nov 9, 2023 | Q3 2023 | -$8.01Est: -$3.15 | -154.3% | - | — | — |
| Aug 8, 2023 | Q2 2023 | -$7.11Est: -$9.54 | +25.5% | - | — | 10-Q |
| May 9, 2023 | Q1 2023 | -$9.00Est: -$15.12 | +40.5% | - | — | — |